Sink or Swim: Lessons in Leadership

Preparing for CPHI 2025 in Frankfurt

The Medicine Maker Presents Sharing is Caring: The Secrets of CGT

The Priorities for Cell and Gene in 2025 and 2026

Eight Reflections on the Acquisition of Bluebird Bio

What’s Your Tech Wishlist for Cell and Gene Therapy?

Intensification, not complication

Inside Charles River's Client-Centric Approach: Interview with Ahmad Hussin, CVP Global CDMO

Innovating Pharma with GELITA: Leadership in Gelatin & Collagen Peptides

Video Interview: Claus Zieler of Astellas and EFPIA

Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

Just – Evotec Biologics Expands in Europe

Redefining Sterile Manufacturing Standards with Kindeva

The Cell Preservation Society

Debra Weiss from the Bill & Melinda Gates Medical Research Institute Talks About her Career

Interview: Courtney Silverthorn from the Foundation for the National Institute’s of Health

April Issue of The Medicine Maker

Interview with Cardinal Health’s Fran Gregory on the High Cost of Pharmaceutical Drugs / Part 2

Interview with Cardinal Health’s Fran Gregory on the High Cost of Pharmaceutical Drugs / Part 1

Interviewing Christian Baber, Chief Portfolio Officer, The Pistoia Alliance

January / February Issue of the Medicine Maker

In Conversation With Joel Eichmann, Green Elephant (Advanced Therapies Week - Phacilitate 2024)

In Conversation With George Eastwood (Advanced Therapies Week- Phacilitate 2024)

In Conversation With Stella Vnook, Likarda (Advanced TherapiesWeek - Phacilitate 2024)

In Conversation With Delara Motlagh, Catalent (Advanced Therapies Week - Phacilitate 2024)

In Conversation with Mike Riley, CEO of Veranova

Vetter, a leading CDMO, on its evolving role and plans for the future

Looking Back on Some of the TOP FDA Approvals from 2023

The Medicine Maker Spelling Bee - Test your pharmaceutical drug name knowledge now!

Ali Pashazadeh from Treehill Partners offers his advice for keeping on track for commercial success.

November / December issue of The Medicine Maker

An interview with Stevanato Group and how its integrated solutions benefit pharma customers.

Discovery to Clinical Supply; How Biosynth’s latest Acquisition Addresses Peptide Customer Needs

In Conversation with Nick Armstrong, Senior Director of Digital Enablement at CAI

October Issue of The Medicine Maker

August Issue of The Medicine Maker

A Timeline of Drug Development for Alzheimer’s Disease

June Issue of the Medicine Maker

In Conversation With Josh Ludwig, Global Commercial Director, ScaleReady at ISCT 2023 Paris Meeting

In Conversation With Phil Vanek, CTO at Gamma Biosciences at the ISCT 2023 Paris Annual Meeting

In Conversation With Angela Osborne, CEO at eXmoor Pharma at the ISCT 2023 Paris Annual Meeting

In Conversation With Vered Caplan, CEO at Orgenesis at the ISCT2023 Paris Annual Meeting

April Issue of The Medicine Maker

Advanced Therapies Week - Phacilitate. Ivan Wall, Head of the Advanced Centre for Advanced Therapies

Advanced Therapies Week - Phacilitate. Natalie Elizalde, Chief Business Development, VIVEBiotech

Advanced Therapies Week - Phacilitate. Stuart Gibb Head of Scientific Strategy CGT, Terumo

Advanced Therapies Week - Phacilitate. Vered Caplan, CEO Orgenesis

Advanced Therapies Week - Phacilitate. Matthew Lakelin, co-founder, Trakcel

Advanced Therapies Week - Phacilitate. Kim Barnes, Executive Vice President, Phacilitate

In Conversation with Christophe le Ret of Umicore PMC at CPhI 2022

In Conversation with Gian Connor of Corning at CPhI 2022

In Conversation with Niek Stapel of Veranova at CPhI 2022

Fluid Management: The Oft-Overlooked Path to Reduced Risk and Increased Efficiency with Erik Storm

Interviewing Keith Horspool at Excipient World 2022

Interviewing David Gough from the Association for Accessible Medicines at Excipient World 2022

Thermo Fisher Scientific: 60 Years of Gibco Innovation

An Interview with Vishal Salvi - Pharma: AI Uptake and Cybersecurity Considerations

Redefining Multiple Myeloma

The Medicine Maker Evaluating Pfizer's Revenues Post-Pandemic

How Can The Pharma Industry Improve Clinical Trials?